TrialCancer prevention research (Philadelphia, Pa.)2012

Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.

Patricia Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.